NeoSome Life Sciences

NeoSome Life Sciences is a private, preclinical-stage CRO offering end-to-end research services to biotech and pharmaceutical companies. Its business model is built on providing rapid, science-driven contract research, utilizing state-of-the-art facilities and a team with extensive experience in animal model development and pharmacology. The company is revenue-generating through its service contracts, positioning itself as a partner for clients aiming to de-risk and accelerate early-stage therapeutic programs. Its accredited operations and focus on complex disease models like oncology provide a foundation for growth in the outsourced R&D market.

Integrated preclinical CRO platform featuring AAALAC-accredited vivarium, BSL-2 suite, oncology clean rooms, surgical suite, and capabilities for developing and validating custom rodent disease models for client research.

NeoSome competes in the fragmented preclinical CRO market against large global players like Charles River Laboratories and Labcorp, as well as numerous niche and regional CROs. Its differentiation is based on its specialized model development expertise, modern facility, regulatory accreditations, and focus on complex disease areas like oncology within a key biotech hub.